My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Oncolytics Biotech Inc. - Common Stock (NQ:ONCY)

0.3763 -0.0353 (-8.58%)

Delayed Quote Updated: 12:59 PM EST, Nov 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Oncolytics Biotech Inc. - Common Stock

< Previous 1 2 3 Next >

There are notable gap-ups and gap-downs in today's session. ↗

July 13, 2026

Via Chartmill

ONCY Stock Rallies On Second Fast Track Designation For Experimental Cancer Drug ↗

February 04, 2026

The agency granted the designation to pelareorep in combination with bevacizumab and leucovorin, fluorouracil, irinotecan for the treatment of certain patients with metastatic colorectal cancer.

Via Stocktwits

Top movers in Tuesday's after hours session ↗

January 20, 2026

Via Chartmill

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

December 04, 2025

As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Preview: Oncolytics Biotech ↗

November 11, 2024

Via Benzinga

Recap: Oncolytics Biotech Q4 Earnings ↗

March 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 15, 2025

Via Benzinga

Earnings Scheduled For August 8, 2025 ↗

August 08, 2025

Via Benzinga

A Preview Of Oncolytics Biotech's Earnings ↗

March 06, 2024

Via Benzinga

Oncolytics Biotech's Earnings Outlook ↗

November 02, 2023

Via Benzinga

Oncolytics Biotech's Earnings: A Preview ↗

August 11, 2023

Via Benzinga

What to Expect from Oncolytics Biotech's Earnings ↗

August 07, 2025

Via Benzinga

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket ↗

May 27, 2025

Via Benzinga

A Look at Oncolytics Biotech's Upcoming Earnings Report ↗

May 13, 2025

Via Benzinga

What's going on in today's pre-market session ↗

April 17, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

5 Analysts Have This to Say About Oncolytics Biotech ↗

June 29, 2023

Via Benzinga

Expert Ratings for Oncolytics Biotech ↗

May 26, 2023

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

Earnings Scheduled For March 7, 2025 ↗

March 07, 2025

Via Benzinga

Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer

August 14, 2024

Extending Survival: Oncolytics Biotech's Pelareorep Shows Promise In Fighting Metastatic Breast Cancer

Via News Direct

ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q1 2024 ↗

May 09, 2024

ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ONCY Stock Earnings: Oncolytics Biotech Beats EPS for Q4 2023 ↗

March 07, 2024

ONCY stock results show that Oncolytics Biotech beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

3 Under-$20 Stocks to Buy for Explosive Returns ↗

August 21, 2023

Are you looking to invest in stocks with massive potential? Here are three under $20 stocks to buy for explosive returns.

Via InvestorPlace

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

Earnings Scheduled For November 3, 2023 ↗

November 03, 2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

Via Benzinga

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 22, 2023

Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private...

Via Benzinga

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition